Amber Koester
Optometrist · Chesterfield, MONPI 1376696708
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 72.9% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $5,939, more than ten times the $377 reported in 2019. Among optometrist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $77.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$6K
- Bausch & Lomb Americas Inc.$447
- Sun Pharmaceutical Industries Inc.$440
- AbbVie$200
- Tarsus Pharmaceuticals, Inc.$174
- Alcon$166
- plus $693 from 10 others
What the payments were for
- Consulting fees$3,37543%
- Speaking & faculty fees$1,20015%
- Travel & lodging$6408%
- Food & beverage$2,60333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 21 | $5,697 |
| Bausch & Lomb Americas Inc. | 14 | $447 |
| Sun Pharmaceutical Industries Inc. | 11 | $440 |
| AbbVie(2 entities) | 8 | $200 |
| Tarsus Pharmaceuticals, Inc. | 6 | $174 |
| Alcon | 8 | $166 |
| Glaukos Corporation | 6 | $162 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $130 |
| Dompe US, Inc. | 4 | $94 |
| Oyster Point Pharma, Inc. | 3 | $83 |
| Novartis | 5 | $72 |
| Kala Pharmaceuticals, Inc. | 3 | $58 |
| Shire North American Group Inc | 3 | $49 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Biotissue Holdings Inc. | 1 | $14 |
| Thea Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$5,291
- CEQUA$235
- INFUSE$125
- MIEBO$103
- XIIDRA$103
How this compares
$7,817 in reported general payments places this provider in the 95th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 44 | $287 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chesterfield
- Sarah HubbardChesterfield$91K
- Patricia GelnerChesterfield$10K
- Kurt BennettChesterfield$10K
- Julie HivelyChesterfield$8K
- Mindy RennardChesterfield$6K
- Andrew BiondoKirkwood$300K
- John McGrealSaint Louis$126K
- Alana KellerWildwood$94K
- Ariel CerenzieSaint Louis$76K
- Geoffrey PowellKansas City$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.